ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 98.2% in March

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 55,700 shares, a growth of 98.2% from the February 29th total of 28,100 shares. Based on an average trading volume of 41,800 shares, the short-interest ratio is presently 1.3 days.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

Several hedge funds have recently modified their holdings of the company. IMC Chicago LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the fourth quarter valued at about $2,435,000. Jane Street Group LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the fourth quarter valued at about $829,000. Toth Financial Advisory Corp lifted its position in shares of ProShares Ultra Nasdaq Biotechnology by 17.3% during the fourth quarter. Toth Financial Advisory Corp now owns 11,241 shares of the exchange traded fund’s stock valued at $641,000 after buying an additional 1,655 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in shares of ProShares Ultra Nasdaq Biotechnology by 523.9% during the third quarter. Tower Research Capital LLC TRC now owns 6,457 shares of the exchange traded fund’s stock valued at $310,000 after buying an additional 5,422 shares during the last quarter. Finally, Walleye Capital LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter valued at about $275,000.

ProShares Ultra Nasdaq Biotechnology Stock Down 0.9 %

ProShares Ultra Nasdaq Biotechnology stock traded down $0.55 during midday trading on Thursday, hitting $57.54. 34,738 shares of the company’s stock were exchanged, compared to its average volume of 43,182. ProShares Ultra Nasdaq Biotechnology has a 12 month low of $40.10 and a 12 month high of $62.45. The firm has a 50-day moving average of $57.70 and a two-hundred day moving average of $52.10.

ProShares Ultra Nasdaq Biotechnology Announces Dividend

The company also recently declared a dividend, which was paid on Wednesday, March 27th. Shareholders of record on Thursday, March 21st were given a dividend of $0.0403 per share. The ex-dividend date of this dividend was Wednesday, March 20th.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.